Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Ascrinvacumab Biosimilar – Anti-ACVRL1, SKR3, TGF-B, TSR-I mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Ascrinvacumab Biosimilar - Anti-ACVRL1, SKR3, TGF-B, TSR-I mAb - Research Grade |
|---|---|
| Source | CAS 1463459-96-2 |
| Species | Homo sapiens |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Ascrinvacumab,PF-03446962,ACVRL1, SKR3, TGF-B, TSR-I,anti-ACVRL1, SKR3, TGF-B, TSR-I |
| Reference | PX-TA1391 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-kappa |
| Clonality | Monoclonal Antibody |
Description of Ascrinvacumab Biosimilar - Anti-ACVRL1, SKR3, TGF-B, TSR-I mAb - Research Grade
General information on Anti-ACVRL1/SKR3/TGF-B/ TSR-I[Homo sapiens] (Ascrinvacumab) Monoclonal Antibody
Ascrinvacumab has been investigated for the treatment of Neoplasms, Advanced Solid Tumors, Carcinoma, Hepatocellular, and Malignant Pleural Mesothelioma.
Related products
Antigen
Human ACVRL1 recombinant protein
PX-P6101 500$
Isotype Control
Human IgG2 Isotype Control antibody (HyHEL-10)
PTX17900 215$
ELISA
Ascrinvacumab ELISA Kit
KPTX226 1404$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.